First of all, we examined the expression level of CDH17 in 156 gastric carcinoma specimens by IHC: 69 (44.3%) of 156 cases were positive, whereas the remaining 87 cases (55.7%) were negative or weak for CDH17 expression (Fig. 1). This evidence concerns the gene CDH17 and gastric carcinoma.